Sir William Harvey first described the systemic circulation in his book De Motu Cordis (On the Motion of the Heart and Blood) published in 1628. 1 However, it was 230 years later before an organized description of congenital heart disease was published by Thomas Bevill Peacock ( Figure 1 ) in his book On Malformations of the Human Heart' in 1858. 2 Thomas Bevill Peacock started medical school at University College, London in 1833, and supplemented his training in Paris, which was at the time the world's leading center for medical education. There, Peacock was exposed to leaders of the "French School" who emphasized clinicopathological correlation and enthusiastically used Laennec's recent invention, the stethoscope. This instrument revolutionized the diagnosis of diseases of the chest and led to unprecedented interest in disorders of the heart. Peacock eventually practiced medicine at St Thomas's Hospital, London. He was highly regarded as a teacher and a popular lecturer. Many of Peacock's lectures and papers dealt with anomalies and diseases of the cardiovascular system. His book, On Malformations of the Human Heart is considered to be the first account to present congenital heart disease (CHD) in an organized fashion. Unlike many of his contemporaries who wrote about CHD cases in haphazard fashion because of a lack of pathophysiologic principles, Peacock combined anatomy and embryology to classify CHD into 4 categories: misplacements of the heart, pericardial abnormalities, cardiac malformations, and irregularities of primary vessels. 3 Peacock's book was well written, included 5 engravings depicting congenital cardiac malformations and was supplemented by useful bibliographies. In a careful analysis of more than 100 cases of CHD for which clinical information was available, Peacock found that three-quarters of the patients had symptoms at birth or shortly thereafter and half of the remainder became symptomatic during the first year of life.
This issue of the journal brings together 8 articles relevant to the practice of congenital cardiac anesthesia. Six articles review the clinicopathological aspects of pulmonary atresia with an intact ventricular septum, truncus arteriosus, and interrupted aortic arch. The remaining 2 articles are original studies about the airway in children with CHD. The review articles are very consistent with Peacock's work describing the embryology, anatomy, and clinical relevance of congenital heart lesions. What Peacock could not imagine is the modern era of imaging these abnormalities with echocardiography, computed tomography (CT) scans, cardiac magnetic resonance imaging (cMRI), and the current therapeutic options in the cardiac catheterization laboratory and surgical approaches. Chikkabyrappa and colleagues describe the perioperative physiology, imaging and management of pulmonary atresia with an intact ventricular septum (PA-IVS) with an accompanying article by Gleich and colleagues describing the perioperative anesthetic considerations. 4, 5 Together, these 2 articles describe this rare, complex CHD, which has a wide anatomic and physiologic spectrum. Chikkabyrappa and colleagues show an excellent pathology specimen of PA-IVS as well as wonderful echocardiographic and angiography images. Gleich and colleagues have 2 key tables that nicely summarize the key considerations and goals of perioperative management of PA-IVS. What both articles do exceptionally well is discuss the management strategies for the spectrum of disease, with excellent flow charts demonstrating the decision pathways for treating this lesion with a biventricular repair, single ventricle palliation or something in between, the socalled "one and a half" repair. Peacock would have been fascinated by these 2 articles with their descriptions of the pathophysiology of PA-IVS. In his book, Peacock describes 3 cases of "obstruction and obliteration of the orifice of the pulmonary artery" and their clinical presentations. I am sure he would have been delighted to learn that 150 years after his book was published, there are therapeutic options for this complex CHD. Using Peacock's classification, PA-IVS would have been considered a "cardiac malformation." Peacock would have classified the next 3 articles on interrupted aortic arch (IAA), as "irregularities of the primary vessels." Friedman starts off this collection with an excellent overview of the perioperative physiology, imaging and management of IAA. 6 Friedman discusses the embryology and pathophysiology of IAA and correlates this with some excellent echocardiographic images and a 3-dimensional CT reconstruction. Following Friedman's account is an outstanding article by Burbano-Vera and colleagues, which has the best color line drawings of the classification of IAA! 7 After seeing the figures in this article, the classification will be clear and memorable. Their overview of the perioperative anesthetic management of IAA leads us to the third and final article in this collection on surgical considerations in IAA by LaPar and Baird. 8 These 2 congenital cardiac surgeons provide an excellent account of the surgical management of IAA in the contemporary surgical era and show how outcomes have improved over the past several decades as surgical and accompanying anesthetic techniques have developed.
The final CHD reviewed in the congenital heart forum of this issue of the journal is truncus arteriosus. While Peacock described defects of the semilunar valves, there is no account of truncus arteriosus in his book. Peacock would have likely classified truncus arteriosus as both a "cardiac malformation" and "irregularities of the primary vessels." The article by Parikh and colleagues on the perioperative anesthetic considerations of truncus arteriosus has an outstanding account of the embryology and anatomy of truncus arteriosus. 9 It is aided by clear drawings of the Collett-Edwards and Van Praagh classifications. Their excellent overview of the anesthetic and surgical management highlights how this condition usually presents shortly after birth with cyanosis and heart failure and requires complete repair early in life. Interestingly, about 10% of cases of truncus arteriosus are associated with IAA, described in the 3 earlier articles.
Thomas Bevill Peacock was a physician scientist. He made astute observations of pathological findings in CHD and made correlations with clinical findings. He would have been very interested in the final 2 studies on acquired airway disease and endotracheal tube use in patients with CHD undergoing cardiac surgery. The first article by Matisoff and colleagues, is a single center, retrospective review of 1395 patients over a 5-year period. 10 The study investigators set out to determine the risk factors associated with the development of severe acquired airway disease in pediatric patients who had undergone surgery for CHD. They found a 1.8% incidence of severe acquired airway disease (vocal cord paralysis or subglottic stenosis). The only statistically significant independent factor associated with severe acquired airway problems was age. Those with severe airway problems were younger and were intubated longer. While the majority of these children required additional procedures under general anesthesia for evaluation and management of their acquired airway issue, it was rare that a tracheostomy was needed.
The second investigative article by Chand and colleagues is a well-conducted prospective, randomized study comparing the use of high-volume, low-pressure microcuff endotracheal tubes to conventional uncuffed tubes.
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The study investigators randomized 80 children to receive one or other of the aforementioned endotracheal tubes and used postextubation stridor as a primary endpoint and secondary outcomes of number of tube changes, amount of anesthetic gas used, and cost incurred. The 2 randomized groups were similar with regard to baseline characteristics and length of time of intubation. They found a 3-fold increase in postextubation stridor in the conventional uncuffed tubes compared with the high-volume low-pressure tubes (30% vs 10%). Secondary outcome measures showed a greater number of tube changes and higher use of anesthetic agent and associated cost in the conventional uncuffed tube group. Chand and colleagues conclude that the reduction in postextubation stridor and cost savings offset the higher costs of modern micro-cuff tubes.
In addition to a complete set of congenital articles, our September issue, has 4 articles with more focus on the management of patients with cardiac disease, including a review on "Prostacyclins in Cardiac Surgery" and 3 clinical challenges. Much like Peacock's approach to seeking a greater understanding of congenital cardiac disease, Seema and colleagues have provided an excellent review that goes into great depth about the application of prostacyclin therapy in the management of cardiac surgery patients. 12 This has applications in both the adult and congenital world, and the authors provide perhaps the most comprehensive and current description of the mechanisms of action of prostacyclins along with current clinical applications. The article also includes a wide array of explanatory figures and tables that illustrate the key sites of action of these drugs, as well as how their clinical indication and applicability. For those practicing cardiac anesthesia, this article clearly illustrates when this drug can be useful in a multitude of clinical scenarios especially in patients undergoing heart and lung transplantation, in patients with pulmonary hypertension, and for patients with right heart failure. Interestingly, these agents have long been studied for their use as antiplatelet agents, yet their widespread use and understanding is still lacking. Seema and colleagues also provide great description their mechanism of action for platelets, including their application in the setting of heparin induced thrombocytopenia. In all, this review should serve as an excellent reference for applications of prostacylins in the setting of cardiac surgery.
Our Clinical Challenges section is meant to present practical articles focused on clinically difficult scenarios with the goal to help our readers gain insight into the decision-making process should they encounter a similar clinical scenario. In our September issue, we present 2 articles that are paired together as they both describe different aspects of managing patients with pheochromocytoma. Pheochromocytoma was first described by Dr Felix Frankel in 1886 in an article where he described an 18-year-old woman with bilateral adrenal sarcoma and angiosarcoma. 13 In our first article, "Echocardiographic Guidance for Surgical Excision of the Intracardiac Component of a Pheochromocytoma," Kurian and colleagues describe a clinical presentation of a large pheochromocytoma that had extended into the inferior vena cava and all the way into the right atrium.
14 Along with the challenges of managing a large endocrine tumor, this case also required transesophageal echocardiography to guide the surgical removal of the mass. The second article on this subject describes a scenario many may have encountered before, which is the adrenal incidentaloma and the subsequent hemodynamic challenges that ensued with an incomplete workup and preoperative management. Chang and colleagues present their case and lead the readers through their case with excellent didactics around the management of patients with pheochromocytoma. 15 Our final article in this issue is focused on a case presentation by Dalia and colleagues describing acute hypotension in the setting of placement of a MitraClip in the interventional suite for the management of mitral regurgitation. 16 MitraClip is fast becoming a first-line therapy for those patients who are not ideal surgical candidates, and so an understanding of the implications of how this device can change the physiology of a patient is crucial. In all, these three clinical challenges provide an excellent reference material, and demonstrate various physiologic concepts that readers can apply in the management of patients with these conditions. Thomas Bevill Peacock would have been proud of all the articles published in this issue of the journal. By standing on the shoulders of others who have come before us and who have made significant contributions to the study of CHD, we have been able to reach the current era of understanding and treatment of CHD. It is important not only to recognize the contributions of those they came before us, but to continue the contributions to our field, as demonstrated with the excellent articles introduced here, so that those who follow us will be able to see even further into the future and perhaps ultimately defeat CHD altogether. In May 1882, while walking into St Thomas's Hospital, Thomas Bevill Peacock, suddenly collapsed and was unconscious. He was carried into a ward that was under his own care but never regained consciousness and died there the next morning. However, his contribution to the field of CHD lives on and should inspire us all to continue our own studies and publications.
